Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccines
View ORCID ProfileYohei Funakoshi, View ORCID ProfileKimikazu Yakushijin, View ORCID ProfileGoh Ohji, Takaji Matsutani, Kazuhiko Doi, Hironori Sakai, Tomoki Sasaki, Takahiro Kusakabe, Sakuya Matsumoto, View ORCID ProfileYasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Taiji Koyama, View ORCID ProfileYoshiaki Nagatani, View ORCID ProfileKeiji Kurata, Shiro Kimbara, View ORCID ProfileYoshinori Imamura, View ORCID ProfileNaomi Kiyota, View ORCID ProfileMitsuhiro Ito, View ORCID ProfileHironobu Minami
doi: https://doi.org/10.1101/2024.01.22.24301315
Yohei Funakoshi
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Kimikazu Yakushijin
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Goh Ohji
2Division of Infection Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Takaji Matsutani
3Research & Development Department, Repertoire Genesis Inc., Ibaraki, Japan
4Translational Research Dept. Maruho Co., Ltd., Kyoto, Japan
Kazuhiko Doi
5R&D, Cellspect Co., Ltd., Morioka, Japan
Hironori Sakai
5R&D, Cellspect Co., Ltd., Morioka, Japan
Tomoki Sasaki
6R&D Department, KAICO Ltd., Fukuoka, Japan
Takahiro Kusakabe
7Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan
Sakuya Matsumoto
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Yasuyuki Saito
8Division of Molecular and Cellular Signaling, Kobe University Graduate School of Medicine, Kobe, Japan
Shinichiro Kawamoto
9Department of Transfusion Medicine and Cell Therapy, Kobe University Hospital, Kobe, Japan
Katsuya Yamamoto
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Taiji Koyama
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Yoshiaki Nagatani
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Keiji Kurata
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Shiro Kimbara
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Yoshinori Imamura
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
Naomi Kiyota
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
10Cancer Center, Kobe University Hospital, Kobe, Japan
Mitsuhiro Ito
11Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
Hironobu Minami
1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
10Cancer Center, Kobe University Hospital, Kobe, Japan

Article usage
Posted January 23, 2024.
Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccines
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Takaji Matsutani, Kazuhiko Doi, Hironori Sakai, Tomoki Sasaki, Takahiro Kusakabe, Sakuya Matsumoto, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Taiji Koyama, Yoshiaki Nagatani, Keiji Kurata, Shiro Kimbara, Yoshinori Imamura, Naomi Kiyota, Mitsuhiro Ito, Hironobu Minami
medRxiv 2024.01.22.24301315; doi: https://doi.org/10.1101/2024.01.22.24301315
Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccines
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Takaji Matsutani, Kazuhiko Doi, Hironori Sakai, Tomoki Sasaki, Takahiro Kusakabe, Sakuya Matsumoto, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Taiji Koyama, Yoshiaki Nagatani, Keiji Kurata, Shiro Kimbara, Yoshinori Imamura, Naomi Kiyota, Mitsuhiro Ito, Hironobu Minami
medRxiv 2024.01.22.24301315; doi: https://doi.org/10.1101/2024.01.22.24301315
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)